SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-056938
Filing Date
2021-02-25
Accepted
2021-02-25 16:06:07
Documents
14
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d138712d8k.htm   iXBRL 8-K 26234
2 EX-99.1 d138712dex991.htm EX-99.1 78198
6 GRAPHIC g138712g57x97.gif GRAPHIC 3753
  Complete submission text file 0001193125-21-056938.txt   239280

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tbio-20210225.xsd EX-101.SCH 3060
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20210225_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20210225_pre.xml EX-101.PRE 10946
7 EXTRACTED XBRL INSTANCE DOCUMENT d138712d8k_htm.xml XML 3220
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38550 | Film No.: 21680251
SIC: 2836 Biological Products, (No Diagnostic Substances)